5430642024-04-012024-09-305430642024-09-305430642024-04-012024-09-30RelatedPartyTransactionDomain15430642024-03-31RelatedPartyTransactionDomain15430642024-09-30RelatedPartyTransactionDomain15430642024-04-012024-09-30RelatedPartyTransactionDomain25430642024-03-31RelatedPartyTransactionDomain25430642024-09-30RelatedPartyTransactionDomain25430642024-04-012024-09-30RelatedPartyTransactionDomain35430642024-03-31RelatedPartyTransactionDomain35430642024-09-30RelatedPartyTransactionDomain35430642024-04-012024-09-30RelatedPartyTransactionDomain45430642024-03-31RelatedPartyTransactionDomain45430642024-09-30RelatedPartyTransactionDomain45430642024-04-012024-09-30RelatedPartyTransactionDomain55430642024-03-31RelatedPartyTransactionDomain55430642024-09-30RelatedPartyTransactionDomain55430642024-04-012024-09-30RelatedPartyTransactionDomain65430642024-03-31RelatedPartyTransactionDomain65430642024-09-30RelatedPartyTransactionDomain65430642024-04-012024-09-30RelatedPartyTransactionDomain75430642024-03-31RelatedPartyTransactionDomain75430642024-09-30RelatedPartyTransactionDomain75430642024-04-012024-09-30RelatedPartyTransactionDomain85430642024-03-31RelatedPartyTransactionDomain85430642024-09-30RelatedPartyTransactionDomain85430642024-04-012024-09-30RelatedPartyTransactionDomain95430642024-03-31RelatedPartyTransactionDomain95430642024-09-30RelatedPartyTransactionDomain95430642024-04-012024-09-30RelatedPartyTransactionDomain105430642024-03-31RelatedPartyTransactionDomain105430642024-09-30RelatedPartyTransactionDomain105430642024-04-012024-09-30RelatedPartyTransactionDomain115430642024-03-31RelatedPartyTransactionDomain115430642024-09-30RelatedPartyTransactionDomain115430642024-04-012024-09-30RelatedPartyTransactionDomain125430642024-03-31RelatedPartyTransactionDomain125430642024-09-30RelatedPartyTransactionDomain125430642024-04-012024-09-30RelatedPartyTransactionDomain135430642024-03-31RelatedPartyTransactionDomain135430642024-09-30RelatedPartyTransactionDomain135430642024-04-012024-09-30RelatedPartyTransactionDomain145430642024-03-31RelatedPartyTransactionDomain145430642024-09-30RelatedPartyTransactionDomain145430642024-04-012024-09-30RelatedPartyTransactionDomain155430642024-03-31RelatedPartyTransactionDomain155430642024-09-30RelatedPartyTransactionDomain155430642024-04-012024-09-30RelatedPartyTransactionDomain165430642024-03-31RelatedPartyTransactionDomain165430642024-09-30RelatedPartyTransactionDomain165430642024-04-012024-09-30RelatedPartyTransactionDomain175430642024-03-31RelatedPartyTransactionDomain175430642024-09-30RelatedPartyTransactionDomain175430642024-04-012024-09-30RelatedPartyTransactionDomain185430642024-03-31RelatedPartyTransactionDomain185430642024-09-30RelatedPartyTransactionDomain185430642024-04-012024-09-30RelatedPartyTransactionDomain195430642024-03-31RelatedPartyTransactionDomain195430642024-09-30RelatedPartyTransactionDomain195430642024-04-012024-09-30RelatedPartyTransactionDomain205430642024-03-31RelatedPartyTransactionDomain205430642024-09-30RelatedPartyTransactionDomain205430642024-04-012024-09-30RelatedPartyTransactionDomain215430642024-03-31RelatedPartyTransactionDomain215430642024-09-30RelatedPartyTransactionDomain215430642024-04-012024-09-30RelatedPartyTransactionDomain225430642024-03-31RelatedPartyTransactionDomain225430642024-09-30RelatedPartyTransactionDomain225430642024-04-012024-09-30RelatedPartyTransactionDomain235430642024-03-31RelatedPartyTransactionDomain235430642024-09-30RelatedPartyTransactionDomain235430642024-04-012024-09-30RelatedPartyTransactionDomain245430642024-03-31RelatedPartyTransactionDomain245430642024-09-30RelatedPartyTransactionDomain24iso4217:INRSUVEN PHARMACEUTICALS LIMITED543064SUVENPHARNA2024-04-012025-03-31First half yearly2024-04-012024-09-30CrorestruetrueNANAfalsetrue2022-02-08https://www.suvenpharm.com/images/pdf/policies/Policy_on_Related_Party_Transactions_2022.pdfSuven Pharmaceuticals LimitedCohance lifesciences limitedCommon PromoterAny other transactionLease Rental income900000NA50000000Suven Pharmaceuticals LimitedCohance lifesciences limitedCommon PromoterSale of goods or services100000000NA770000000Suven Pharmaceuticals LimitedCohance lifesciences limitedCommon PromoterAny other transactionConsultancy charges income2300000NA60000000Suven Pharmaceuticals LimitedCasper pharma private limitedWholly Owned SubsidiaryAny other transactionLease Rental income0NA20000000Suven Pharmaceuticals LimitedCasper pharma private limitedWholly Owned SubsidiarySale of goods or services0NA670000000Suven Pharmaceuticals LimitedMr.Vivek Sharma(w.e.f September 20, 2024)Key management personnelRemuneration0NA1360000000Suven Pharmaceuticals LimitedMr.Annaswamy Vaidheesh (till September 19, 2024)Key management personnelRemuneration0NA2980000000Suven Pharmaceuticals LimitedMr.Sudhir Kumar SinghKey management personnelRemuneration0NA2310000000Suven Pharmaceuticals LimitedMr.Himanshu AgarwalKey management personnelRemuneration0NA2060000000inculdes advance of 0.75 croresSuven Pharmaceuticals LimitedMr.Kundan Kumar JhaKey management personnelRemuneration0NA100000000Suven Pharmaceuticals LimitedMr.Vinod RaoKey management personnelAny other transactionIndependent director fee3000000NA150000000Suven Pharmaceuticals LimitedMr.Kumarapuram Gopalakrishnan AnanthakrishnanKey management personnelAny other transactionIndependent director fee3000000NA150000000Suven Pharmaceuticals LimitedMrs.Matangi GowrishankarKey management personnelAny other transactionIndependent director fee3000000NA150000000Suven Pharmaceuticals LimitedMr.Pravin Udhyavara Bhadya RaoKey management personnelAny other transactionIndependent director fee3000000NA150000000Sapala Organics Private LimitedDr. Paidi Yella Reddy (Director)Key management personnelRemuneration0NA370000000Sapala Organics Private LimitedSampada Laboratories Pvt LtdEnterprise over which KMP have significant influenceAny other transactionHouse keeping and Security services0NA320000000Sapala Organics Private LimitedSampada Laboratories Pvt LtdEnterprise over which KMP have significant influenceAny other transactionTravelling expenses0NA10000000Sapala Organics Private LimitedSampada Laboratories Pvt LtdEnterprise over which KMP have significant influenceAny other transactionReimbursement of Gratuity0NA10000000Sapala Organics Private LimitedRasayan IncShareholderPurchase of goods or services0NA380000000Sapala Organics Private LimitedSapala Co Ltd, JapanEnterprise over which KMP have significant influenceSale of goods or services0NA1820000000Sapala Organics Private LimitedSapala Co Ltd, JapanEnterprise over which KMP have significant influencePurchase of goods or services0NA70000000Casper Pharma Private LimitedCohance lifesciences limitedCommon PromoterAny other transactionRental expense0NA50000000Casper Pharma Private LimitedRohit Kumar AgarwalKey management personnelRemuneration0NA70000000Sapala Organics Private LimitedCohance lifesciences limitedFellow subsidiary with effect from July 12, 2024Any other transactionConsultancy charges expense0NA60000000141400000